Neurodegenerative Diseases: Biology & Therapeutics
December 2 - 4, 2020 Virtual
Abstract Deadline: September 18, 2020


Aaron Gitler, Stanford University
Richard Ransohoff
, Third Rock Ventures
Scott Small, Columbia University
Li-Huei Tsai, Massachusetts Institute of Technology


The current COVID-19 situation is challenging and difficult for all of us - we hope this virtual conference will allow colleagues to share and discuss their latest research, while under travel and stay-at-home restrictions.


The eleventh meeting on Neurodegenerative Diseases is going fully virtual and will begin late morning EST on Wednesday, December 2, and will conclude late afternoon EST on Friday, December 4, 2020.

A primary goal of the meeting is to provide a forum where medical scientists from academia can interact with scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for neurodegenerative diseases has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia and industry meet regularly to exchange data and ideas.

This meeting will consist of six oral sessions plus a poster session throughout the meeting. The aim is to populate half of each oral session with speakers from academia and the other half from industry; speakers will be invited as well as selected from submitted abstracts.

Tentative Topics:
  • Propagation of Neurodegenerative Disease
  • Network Mechanisms of Neurodegenerative Disease
  • Neuroinflammation & Glial Biology of Neurodegeneration
  • ApoE and Lipid Metabolism
  • RNA Metabolism in Neurodegenerative Disease
  • The Endolysosome, Autophagy and Other Targets in Therapeutics
Session Chairs:
Christopher Henderson, Biogen
Joachim Herz, UT Southwestern
Henne Holstege, Vrije Universiteit Amsterdam, Netherlands
Sally John, Biogen
Anne Schaefer, Icahn School of Medicine at Mount Sinai

Invited Speakers:
Robert Brown, University of Massachusetts Medical School
Olav Michael Andersen, Aarhus University, Denmark
Frank Bennett, Ionis Pharmaceuticals
Gonçalo Castelo-Branco, Karolinska Institutet, Sweden
Michael Heneka, German Center for Neurodegenerative Diseases (DZNE)
David Holtzman, Washington University School of Medicine
Yadong Huang, University of California, San Francisco
Martin Kampmann, University of California, San Francisco
Jennifer Lippincott-Schwartz, HHMI Janelia Farm Research Campus
Leonard Petrucelli, Mayo Clinic

Keynote Speaker:
Virginia Lee, University of Pennsylvania Perelman School of Medicine

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentations will be made by the organizers and individual session chairs. The status of abstracts (i.e., talk or poster) will be posted as soon as decisions have been made by the organizers. Please bring this announcement to the attention of any of your colleagues who may be interested in participating in the meeting.

All questions pertaining to registration, fees, abstract submission or any other matters may be directed to Catie Carr at

Cold Spring Harbor Laboratory is eager to have as many young people as possible attend this meeting. As such, we have some funds set aside to partially support students and postdocs. Please register and apply in writing to Catie Carr at stating your eligibility and need for financial support. Preference will be given to those submitting abstracts.

Partial support for this meeting provided by: National Institute of Neurological Diseases & Stroke 

Social Media:

The designated hashtag for this meeting is #cshldegen. Note that you must obtain permission from an individual presenter before live-tweeting or discussing his/her talk, poster, or research results on social media. Click the Policies tab above to see our full Confidentiality & Reporting Policy.


Virtual Academic Package: $240
Virtual Graduate Student Package: $145
Virtual Corporate Package: $360
Virtual Reduced Package (LMIC/MSI only): $25
 (see special support from IBRO and CZI below)

Lab Group Discounts (not departmental or institutional discounts)

Labs registering 4 people: 20% discount off applicable fees
Labs registering 5 people: 25% discount off applicable fees
Labs registering 6 people: 30% discount off applicable fees

To be eligible for lab group discounts, please submit a list of lab members planning to attend in advance of registration to Catie Carr  to establish appropriate discounted fees. Please include a link to your lab web page for verification purposes. Prior payments will be included in the group discount calculation.

IBRO/International Brain Research Organization are generously supporting the participation of a limited number of individuals from US/Canadian Minority Serving Institutions
Limit: 65 attendees / limit per institution: 5 

Chan Zuckerberg Initiative are generously supporting the participation of a limited number of individuals from Low & Middle Income Countries or US/Canadian Minority Serving Institutions
Limit: 300 attendees / limit per institution: 10 (including IBRO support)

Reduced Pricing for Individuals from US/Canadian Minority Serving Institutions (check eligibility): $25

Reduced Pricing for Individuals from Low & Middle Income Countries (check eligibility): $25

Virtual 3 day live meeting + 6 weeks archive access

Card image cap
~60 talks / 6 sessions
(late am/early pm)
~20 total hours with interactive Q&A
Card image cap
~125 posters with
dedicated slack channels for each poster
Card image cap
Digital program in PDF format
Card image cap
Leading Strand video archive access to talks
Card image cap
Twitter for meeting news & general comments